-
557364-5MG
INSOLUTION ROSCOVITINE - CALBIOCHEM (C005B-230055)
Price: $528.94List Price: $587.72A potent and selective inhibitor of cyclin-dependent kinases (Cdks). Exhibits greater inhibitory potency compared to olomoucine (Cat. -
Lib412022-100μl-well
Kinase Inhibitor Library (C007B-571777)
Price: $88,068.97List Price: $97,854.42• A unique collection of 1431 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS)• Targets kinases such as EGFR, PI3K, Aurora Kinase, CDK, and MEK• Some inhibitors have been approved by the FDA• Most are ATP competi -
Lib412022-2×100μl-well
Kinase Inhibitor Library (C007B-571778)
Price: $134,925.08List Price: $149,916.75• A unique collection of 1431 kinase inhibitors for high throughput screening (HTS) and high content screening (HCS)• Targets kinases such as EGFR, PI3K, Aurora Kinase, CDK, and MEK• Some inhibitors have been approved by the FDA• Most are ATP competi -
L408045-1ml
Lifirafenib (BGB-283) (C007B-203323)
Price: $738.12List Price: $820.14InformationLifirafenib (BGB-283, Beigene-283) potently inhibitsRAFfamily kinases andEGFRactivities in biochemical assays withIC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.In vitroIn -
L413873-10mg
Lifirafenib (BGB-283) (C007B-203596)
Price: $251.54List Price: $279.49InformationLifirafenib (BGB-283, Beigene-283) potently inhibitsRAFfamily kinases andEGFRactivities in biochemical assays withIC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.TargetsWT -
L413873-1mg
Lifirafenib (BGB-283) (C007B-203597)
Price: $79.80List Price: $88.67InformationLifirafenib (BGB-283, Beigene-283) potently inhibitsRAFfamily kinases andEGFRactivities in biochemical assays withIC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.TargetsWT -
L413873-25mg
Lifirafenib (BGB-283) (C007B-203598)
Price: $426.41List Price: $473.78InformationLifirafenib (BGB-283, Beigene-283) potently inhibitsRAFfamily kinases andEGFRactivities in biochemical assays withIC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.TargetsWT -
L413873-50mg
Lifirafenib (BGB-283) (C007B-203599)
Price: $680.96List Price: $756.62InformationLifirafenib (BGB-283, Beigene-283) potently inhibitsRAFfamily kinases andEGFRactivities in biochemical assays withIC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.TargetsWT -
L413873-5mg
Lifirafenib (BGB-283) (C007B-203600)
Price: $169.44List Price: $188.27InformationLifirafenib (BGB-283, Beigene-283) potently inhibitsRAFfamily kinases andEGFRactivities in biochemical assays withIC50values of 23, 29 and 495 nM for the recombinant BRAFV600E kinase domain, EGFR and EGFR T790M/L858R mutant.TargetsWT -
-
-
SML1890-5MG
MK204
Price: $253.46List Price: $281.62Biochem/physiol Actions MK204 is a potent and selective inhibitor of aldo-keto reductase family member 1B10 (AKR1B10). AKR1B10 is induced in several cancer types, in particular, hepatocellular carcinoma, and may be involved with drug resistance.